Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214246 · ClinicalTrials.gov registry record
Follicular Fluid microRNAs in Ovarian Aging and Reproduction
A clinical trial of Ovarian Aging and InVitro Fertilization, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07214246 is a study of Ovarian Aging and InVitro Fertilization that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07214246, a study of Ovarian Aging and InVitro Fertilization, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the role of exosomal microRNAs (miRNAs) in follicular fluid (FF) as biomarkers of ovarian aging and predictors of in vitro fertilization (IVF) outcomes. The goal is to identify noninvasive molecular markers that correlate with oocyte quality and reproductive potential, particularly in women of advanced maternal age.
Conditions Studied
Interventions
- OTHER No Interventions
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-22 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07214246
The ClinicalTrials.gov registry entry for NCT07214246 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Ovarian Aging appearing as the primary indexed condition, and to 1 intervention - of which No Interventions is the first listed.
NCT07214246 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07214246 about?
NCT07214246 is a clinical study titled "Follicular Fluid microRNAs in Ovarian Aging and Reproduction". The purpose of this study is to investigate the role of exosomal microRNAs (miRNAs) in follicular fluid (FF) as biomarkers of ovarian aging and predictors of in vitro fertilization (IVF) outcomes. The goal is to identify noninvasive molecular markers that correlate with oocyte quality and reproducti...
What is the current status of trial NCT07214246?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-09-22. Estimated completion is 2026-09.
What conditions does trial NCT07214246 study?
This clinical trial studies the following conditions: Ovarian Aging, InVitro Fertilization, In Vitro Fertilisation (IVF) Treatment, In Vitro Fertilization Outcome.
What interventions are being tested in trial NCT07214246?
The interventions under investigation include: No Interventions (OTHER).
Who is sponsoring clinical trial NCT07214246?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07214246 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.